Association Between the Oral Health Status and Sociodemographic Factors Among 5–15-Year-Old Schoolchildren from Mallorca, Spain—A Cross-Sectional Study
Abstract
Background: Oral health is a key indicator of general health, well-being, and quality of life. Sociodemographic factors can affect children’s oral health status. The aim of this study was to analyze the sociodemographic factors that influence the oral health of schoolchildren in Mallorca. Materials and methods: We conducted a cross-sectional observational epidemiological study in Mallorca, analyzing different indicators of oral health, such as the DMFT/dmft index and the Community Periodontal Index (CPI), and sociodemographic variables among 718 schoolchildren aged 5–6, 12 and 15 years. Results: The DMFT (Decayed, Missing, and Filled Permanent Teeth) caries index was higher in public (Pub) schools than in private/charter (P/C) schools for children in the sixth grade of elementary school (Pub, 0.6918 ± 1.272; P/C, 0.323 ± 0.824; p < 0.05) and in the fourth year of secondary school (Pub, 1.178 ± 1.724; P/C, 0.627 ± 1.195; p < 0.05), as determined using a t-test. First-grade elementary students with more highly educated mothers/guardians had a lower rate of DMFT (Decayed, Missing, and Filled Primary Teeth) caries than those whose mothers obtained only elementary-level education (higher, 0.800 ± 1.616; elementary, 3.333 ± 3.393; p < 0.05). Regarding periodontal health, we observed that sixth-grade elementary schoolchildren with more highly educated mothers/guardians had more healthy sextants (higher, 3.987 ± 1.977; elementary, 1.333 ± 2.461; p < 0.001). Conclusions: The…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.